Real-time enrollment status for this hyperkalaemia clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 4:55 AM UTC
| NCT Number | NCT05766839 |
| Recruiting Status | Recruiting |
| Condition | Hyperkalaemia |
| Phase | PHASE2 |
| Target Enrollment | 32 participants |
| Active Locations | 13 sites in the US |
| Sponsor | Vifor Pharma, Inc. |
| Last Updated on CT.gov | June 1, 2026 (Jun 1, 2026) |
As of July 18, 2026: Clinical trial NCT05766839 is currently recruiting participants. This phase2 study for hyperkalaemia is actively seeking new participants at 13 locations across the United States. The study is sponsored by Vifor Pharma, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05766839 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 13 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05766839 was last updated Jun 1, 2026 (June 1, 2026). HelloStudys verifies this status automatically.